Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Lactate oxidase

Copy Product Info
😃Good
Hot
Catalog No. T78348Cas No. 9028-72-2

Lactate oxidase is an FMN-dependent enzyme that specifically catalyzes l-lactate, destroys lactate-activated RAS and PI3K oncogenic signaling, and can be used in the diagnosis and treatment of cancer.

Lactate oxidase

Lactate oxidase

Copy Product Info
😃Good
Hot
Catalog No. T78348Cas No. 9028-72-2
Lactate oxidase is an FMN-dependent enzyme that specifically catalyzes l-lactate, destroys lactate-activated RAS and PI3K oncogenic signaling, and can be used in the diagnosis and treatment of cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
100 U$166-In Stock
500 U$398-In Stock
1 KU$597-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Lactate oxidase is an FMN-dependent enzyme that specifically catalyzes l-lactate, destroys lactate-activated RAS and PI3K oncogenic signaling, and can be used in the diagnosis and treatment of cancer.
In vitro
The effect of Lactate oxidase expression on the release of lactate was assessed in HEK293 cells and primary astrocytes. Lactate concentration in the conditioned extracellular media was significantly decreased by Lactate oxidase (33.2% in HEK293 cells and 15.4% in astrocytes), reflecting limited constitutive lactate release. Expression of Lactate oxidase by astrocytes in organotypic slices significantly decreased lactate tone compared to control slices. [1]
In vivo
Analysis of the expression of tdTomato indicated that LVV‐sGFAP‐Lactate oxidase‐IRES‐tdTomato transduced astrocytes within a limited area of the dorsal hippocampus. Compared to control mice, mice expressing Lactate oxidase in astrocytes exhibited a significantly increased locomotor activity in the hole board test without altering the number of head dips, suggesting elevated novelty‐induced activity. In addition, mice expressing Lactate oxidase showed substantially less freezing behavior during the habituation session in the trace fear conditioning test, indicative of elevated reactivity to unfamiliar environments. Collectively, our findings suggest that expression of Lactate oxidase in hippocampal astrocytes led to increased responsiveness to novelty in mice that could facilitate some types of recognition memory. [1]
Chemical Properties
Cas No.9028-72-2
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 8 mg/mL, Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Lactate oxidase | purchase Lactate oxidase | Lactate oxidase cost | order Lactate oxidase | Lactate oxidase in vivo | Lactate oxidase in vitro